Atara Biotherapeutics (ATRA) Financial Statements

1,201 Followers

Atara Biotherapeutics Financial Overview

Atara Biotherapeutics's market cap is currently $43.84M. The company's EPS TTM is $3.16; its P/E ratio is -16.66; Atara Biotherapeutics is scheduled to report earnings on May 6, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 120.77M	$ 128.94M	$ 8.57M	$ 63.57M	$ 20.34M
Gross Profit	$ 99.56M	$ 107.93M	$ -313.00K	$ 63.57M	$ -261.66M
Operating Income	$ 35.86M	$ -83.44M	$ -276.01M	$ -280.51M	$ -340.46M
EBITDA	$ 50.41M	$ -75.75M	$ -266.00M	$ -222.26M	$ -331.12M
Net Income	$ 32.69M	$ -85.40M	$ -276.13M	$ -228.30M	$ -340.14M
Balance Sheet
Cash & Short-Term Investments	$ 8.48M	$ 42.50M	$ 51.73M	$ 242.82M	$ 371.07M
Total Assets	$ 20.23M	$ 109.10M	$ 165.50M	$ 376.42M	$ 468.13M
Total Debt	$ 52.80M	$ 43.83M	$ 57.87M	$ 71.70M	$ 28.27M
Net Debt	$ 44.32M	$ 18.80M	$ 32.03M	$ -21.24M	$ -77.81M
Total Liabilities	$ 58.74M	$ 206.38M	$ 264.74M	$ 249.78M	$ 188.51M
Stockholders' Equity	$ -38.50M	$ -97.28M	$ -99.23M	$ 126.64M	$ 279.61M
Cash Flow
Free Cash Flow	$ -50.94M	$ -68.96M	$ -194.20M	$ -274.62M	$ -231.10M
Operating Cash Flow	$ -50.94M	$ -68.72M	$ -192.98M	$ -270.43M	$ -220.52M
Investing Cash Flow	$ 18.15M	$ 8.62M	$ 123.87M	$ 202.96M	$ 22.26M
Financing Cash Flow	$ 16.10M	$ 59.28M	$ 2.01M	$ 53.08M	$ 103.94M

Currency in USD

Atara Biotherapeutics Earnings and Revenue History

Income Statement >

Atara Biotherapeutics Debt to Assets

Balance Sheet >

Atara Biotherapeutics Cash Flow

Cash Flow >

Atara Biotherapeutics Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >